These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35506765)

  • 1. Effects of the T337M and G391V disease-related variants on human phosphoglucomutase 1: structural disruptions large and small.
    Stiers KM; Owuocha LF; Beamer LJ
    Acta Crystallogr F Struct Biol Commun; 2022 May; 78(Pt 5):200-209. PubMed ID: 35506765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A missense variant remote from the active site impairs stability of human phosphoglucomutase 1.
    Stiers KM; Hansen RP; Daghlas BA; Mason KN; Zhu JS; Jakeman DL; Beamer LJ
    J Inherit Metab Dis; 2020 Jul; 43(4):861-870. PubMed ID: 32057119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Hotspot for Disease-Associated Variants of Human PGM1 Is Associated with Impaired Ligand Binding and Loop Dynamics.
    Stiers KM; Beamer LJ
    Structure; 2018 Oct; 26(10):1337-1345.e3. PubMed ID: 30122451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asp263 missense variants perturb the active site of human phosphoglucomutase 1.
    Stiers KM; Graham AC; Kain BN; Beamer LJ
    FEBS J; 2017 Mar; 284(6):937-947. PubMed ID: 28117557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induced Structural Disorder as a Molecular Mechanism for Enzyme Dysfunction in Phosphoglucomutase 1 Deficiency.
    Stiers KM; Kain BN; Graham AC; Beamer LJ
    J Mol Biol; 2016 Apr; 428(8):1493-505. PubMed ID: 26972339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme dysfunction at atomic resolution: Disease-associated variants of human phosphoglucomutase-1.
    Beamer LJ
    Biochimie; 2021 Apr; 183():44-48. PubMed ID: 32898648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in hereditary phosphoglucomutase 1 deficiency map to key regions of enzyme structure and function.
    Beamer LJ
    J Inherit Metab Dis; 2015 Mar; 38(2):243-56. PubMed ID: 25168163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compromised catalysis and potential folding defects in in vitro studies of missense mutants associated with hereditary phosphoglucomutase 1 deficiency.
    Lee Y; Stiers KM; Kain BN; Beamer LJ
    J Biol Chem; 2014 Nov; 289(46):32010-32019. PubMed ID: 25288802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for substrate and product recognition in human phosphoglucomutase-1 (PGM1) isoform 2, a member of the α-D-phosphohexomutase superfamily.
    Backe PH; Laerdahl JK; Kittelsen LS; Dalhus B; Mørkrid L; Bjørås M
    Sci Rep; 2020 Mar; 10(1):5656. PubMed ID: 32221390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycogen storage disease-like phenotype with central nervous system involvement in a PGM1-CDG patient.
    Ondruskova N; Honzik T; Vondrackova A; Tesarova M; Zeman J; Hansikova H
    Neuro Endocrinol Lett; 2014; 35(2):137-41. PubMed ID: 24878975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and molecular genetic characterization of two patients with mutations in the phosphoglucomutase 1 (PGM1) gene.
    Ding Y; Li N; Chang G; Li J; Yao R; Shen Y; Wang J; Huang X; Wang X
    J Pediatr Endocrinol Metab; 2018 Jul; 31(7):781-788. PubMed ID: 29858906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Destabilization and Degradation of a Disease-Linked PGM1 Protein Variant.
    Gouliaev F; Jonsson N; Gersing S; Lisby M; Lindorff-Larsen K; Hartmann-Petersen R
    Biochemistry; 2024 Jun; 63(11):1423-1433. PubMed ID: 38743592
    [No Abstract]   [Full Text] [Related]  

  • 13. Multiple phenotypes in phosphoglucomutase 1 deficiency.
    Tegtmeyer LC; Rust S; van Scherpenzeel M; Ng BG; Losfeld ME; Timal S; Raymond K; He P; Ichikawa M; Veltman J; Huijben K; Shin YS; Sharma V; Adamowicz M; Lammens M; Reunert J; Witten A; Schrapers E; Matthijs G; Jaeken J; Rymen D; Stojkovic T; Laforêt P; Petit F; Aumaître O; Czarnowska E; Piraud M; Podskarbi T; Stanley CA; Matalon R; Burda P; Seyyedi S; Debus V; Socha P; Sykut-Cegielska J; van Spronsen F; de Meirleir L; Vajro P; DeClue T; Ficicioglu C; Wada Y; Wevers RA; Vanderschaeghe D; Callewaert N; Fingerhut R; van Schaftingen E; Freeze HH; Morava E; Lefeber DJ; Marquardt T
    N Engl J Med; 2014 Feb; 370(6):533-42. PubMed ID: 24499211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure and Characterization of Phosphoglucomutase 5 from Atlantic and Baltic Herring-An Inactive Enzyme with Intact Substrate Binding.
    Gustafsson R; Eckhard U; Ye W; Enbody ED; Pettersson M; Jemth P; Andersson L; Selmer M
    Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33287293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biology, Mechanism, and Structure of Enzymes in the α-d-Phosphohexomutase Superfamily.
    Stiers KM; Muenks AG; Beamer LJ
    Adv Protein Chem Struct Biol; 2017; 109():265-304. PubMed ID: 28683921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphoglucomutase-1 deficiency: Early presentation, metabolic management and detection in neonatal blood spots.
    Conte F; Morava E; Bakar NA; Wortmann SB; Poerink AJ; Grunewald S; Crushell E; Al-Gazali L; de Vries MC; Mørkrid L; Hertecant J; Brocke Holmefjord KS; Kronn D; Feigenbaum A; Fingerhut R; Wong SY; van Scherpenzeel M; Voermans NC; Lefeber DJ
    Mol Genet Metab; 2020; 131(1-2):135-146. PubMed ID: 33342467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment and Impacts of Phosphorylation on Protein Flexibility of the α-d-Phosphohexomutases.
    Stiers KM; Beamer LJ
    Methods Enzymol; 2018; 607():241-267. PubMed ID: 30149860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphoglucomutase-1 deficiency: Intrafamilial clinical variability and common secondary adrenal insufficiency.
    Loewenthal N; Haim A; Parvari R; Hershkovitz E
    Am J Med Genet A; 2015 Dec; 167A(12):3139-43. PubMed ID: 26768186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel congenital disorder of glycosylation type without central nervous system involvement caused by mutations in the phosphoglucomutase 1 gene.
    Pérez B; Medrano C; Ecay MJ; Ruiz-Sala P; Martínez-Pardo M; Ugarte M; Pérez-Cerdá C
    J Inherit Metab Dis; 2013 May; 36(3):535-42. PubMed ID: 22976764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The congenital disorder of glycosylation in PGM1 (PGM1-CDG) can cause severe cardiomyopathy and unexpected sudden cardiac death in childhood.
    Fernlund E; Andersson O; Ellegård R; Årstrand HK; Green H; Olsson H; Gunnarsson C
    Forensic Sci Int Genet; 2019 Nov; 43():102111. PubMed ID: 31563034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.